Ali Behbahani Transaction History

Date Transaction Value Shares Traded Form
Sep 16 2024
BUY
Conversion of derivative security
-
3,114,486
Sep 16 2024
BUY
Open market or private purchase
$8,000,000 $16.0 p/Share
500,000

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RGLS
Regulus Therapeutics Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
UTRS
MINERVA SURGICAL INC Healthcare
MTCR
Metacrine, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
ACLX
Arcellx, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SVRA
Savara Inc Healthcare
FREQ
Frequency Therapeutics, Inc. Healthcare
AB

Ali Behbahani

Timonium, MD

Track Institutional and Insider Activities on MBX

Follow MBX Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MBX shares.

Notify only if

Insider Trading

Get notified when an Mbx Biosciences, Inc. insider buys or sells MBX shares.

Notify only if

News

Receive news related to MBX Biosciences, Inc.

Track Activities on MBX